Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLAMP: MMF and Allopurinol with Chemotherapy in Relapsed SCLC
NCT05049863Phase 1Terminated
- Sponsor
- Washington University School of Medicine
- Start
- Feb 2023
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of mycophenolate mofetil and allopurinol in small cell lung cancer (SCLC) (3 arms), sponsored by Washington University School of Medicine. Primary endpoints: Number of study treatment related adverse events, Overall Response Rate and 3 more. Started Feb 2023; status: terminated.
02
Drugs
mycophenolate mofetilallopurinol
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT05049863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05049863.